Poly(β-amino ester)s-Based Delivery Systems for Targeted Transdermal Vaccination

Nucleic acid vaccines have become a transformative technology to fight emerging infectious diseases and cancer. Delivery of such via the transdermal route could boost their efficacy given the complex immune cell reservoir present in the skin that is capable of engendering robust immune responses. We...

Full description

Bibliographic Details
Main Authors: Puigmal, Núria, Ramos, Víctor, Artzi, Natalie, Borrós, Salvador
Other Authors: Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Format: Article
Published: Multidisciplinary Digital Publishing Institute 2023
Online Access:https://hdl.handle.net/1721.1/150602
_version_ 1811081474044067840
author Puigmal, Núria
Ramos, Víctor
Artzi, Natalie
Borrós, Salvador
author2 Massachusetts Institute of Technology. Institute for Medical Engineering & Science
author_facet Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Puigmal, Núria
Ramos, Víctor
Artzi, Natalie
Borrós, Salvador
author_sort Puigmal, Núria
collection MIT
description Nucleic acid vaccines have become a transformative technology to fight emerging infectious diseases and cancer. Delivery of such via the transdermal route could boost their efficacy given the complex immune cell reservoir present in the skin that is capable of engendering robust immune responses. We have generated a novel library of vectors derived from poly(β-amino ester)s (PBAEs) including oligopeptide-termini and a natural ligand, mannose, for targeted transfection of antigen presenting cells (APCs) such as Langerhans cells and macrophages in the dermal milieu. Our results reaffirmed terminal decoration of PBAEs with oligopeptide chains as a powerful tool to induce cell-specific transfection, identifying an outstanding candidate with a ten-fold increased transfection efficiency over commercial controls in vitro. The inclusion of mannose in the PBAE backbone rendered an additive effect and increased transfection levels, achieving superior gene expression in human monocyte-derived dendritic cells and other accessory antigen presenting cells. Moreover, top performing candidates were capable of mediating surface gene transfer when deposited as polyelectrolyte films onto transdermal devices such as microneedles, offering alternatives to conventional hypodermic administration. We predict that the use of highly efficient delivery vectors derived from PBAEs could advance clinical translation of nucleic acid vaccination over protein- and peptide-based strategies.
first_indexed 2024-09-23T11:47:15Z
format Article
id mit-1721.1/150602
institution Massachusetts Institute of Technology
last_indexed 2024-09-23T11:47:15Z
publishDate 2023
publisher Multidisciplinary Digital Publishing Institute
record_format dspace
spelling mit-1721.1/1506022024-03-20T20:04:44Z Poly(β-amino ester)s-Based Delivery Systems for Targeted Transdermal Vaccination Puigmal, Núria Ramos, Víctor Artzi, Natalie Borrós, Salvador Massachusetts Institute of Technology. Institute for Medical Engineering & Science Nucleic acid vaccines have become a transformative technology to fight emerging infectious diseases and cancer. Delivery of such via the transdermal route could boost their efficacy given the complex immune cell reservoir present in the skin that is capable of engendering robust immune responses. We have generated a novel library of vectors derived from poly(β-amino ester)s (PBAEs) including oligopeptide-termini and a natural ligand, mannose, for targeted transfection of antigen presenting cells (APCs) such as Langerhans cells and macrophages in the dermal milieu. Our results reaffirmed terminal decoration of PBAEs with oligopeptide chains as a powerful tool to induce cell-specific transfection, identifying an outstanding candidate with a ten-fold increased transfection efficiency over commercial controls in vitro. The inclusion of mannose in the PBAE backbone rendered an additive effect and increased transfection levels, achieving superior gene expression in human monocyte-derived dendritic cells and other accessory antigen presenting cells. Moreover, top performing candidates were capable of mediating surface gene transfer when deposited as polyelectrolyte films onto transdermal devices such as microneedles, offering alternatives to conventional hypodermic administration. We predict that the use of highly efficient delivery vectors derived from PBAEs could advance clinical translation of nucleic acid vaccination over protein- and peptide-based strategies. 2023-05-08T17:29:58Z 2023-05-08T17:29:58Z 2023-04-17 2023-04-27T13:50:39Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/150602 Pharmaceutics 15 (4): 1262 (2023) PUBLISHER_CC http://dx.doi.org/10.3390/pharmaceutics15041262 Creative Commons Attribution http://creativecommons.org/licenses/by/4.0/ application/pdf Multidisciplinary Digital Publishing Institute Multidisciplinary Digital Publishing Institute
spellingShingle Puigmal, Núria
Ramos, Víctor
Artzi, Natalie
Borrós, Salvador
Poly(β-amino ester)s-Based Delivery Systems for Targeted Transdermal Vaccination
title Poly(β-amino ester)s-Based Delivery Systems for Targeted Transdermal Vaccination
title_full Poly(β-amino ester)s-Based Delivery Systems for Targeted Transdermal Vaccination
title_fullStr Poly(β-amino ester)s-Based Delivery Systems for Targeted Transdermal Vaccination
title_full_unstemmed Poly(β-amino ester)s-Based Delivery Systems for Targeted Transdermal Vaccination
title_short Poly(β-amino ester)s-Based Delivery Systems for Targeted Transdermal Vaccination
title_sort poly beta amino ester s based delivery systems for targeted transdermal vaccination
url https://hdl.handle.net/1721.1/150602
work_keys_str_mv AT puigmalnuria polybetaaminoestersbaseddeliverysystemsfortargetedtransdermalvaccination
AT ramosvictor polybetaaminoestersbaseddeliverysystemsfortargetedtransdermalvaccination
AT artzinatalie polybetaaminoestersbaseddeliverysystemsfortargetedtransdermalvaccination
AT borrossalvador polybetaaminoestersbaseddeliverysystemsfortargetedtransdermalvaccination